HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mahesh Mistry Selected Research

PF-06263507

1/2021ASN004, A 5T4-targeting scFv-Fc Antibody-Drug Conjugate with High Drug-to-Antibody Ratio, Induces Complete and Durable Tumor Regressions in Preclinical Models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mahesh Mistry Research Topics

Disease

1Neoplasms (Cancer)
01/2021
1Cardiovascular Diseases (Cardiovascular Disease)
07/2011
1Heart Failure
07/2011
1Neuroblastoma
07/2011
1Hypertension (High Blood Pressure)
06/2003
1Insulin Resistance
06/2003

Drug/Important Bio-Agent (IBA)

1Pharmaceutical PreparationsIBA
01/2021
1Glycoproteins (Glycoprotein)IBA
01/2021
1Ado-Trastuzumab EmtansineIBA
01/2021
1AntigensIBA
01/2021
1Immunoconjugates (Immunoconjugate)IBA
01/2021
1PF-06263507IBA
01/2021
1Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA
07/2011
1flubrobenguaneIBA
07/2011
1DiureticsIBA
06/2003
1GW002 peptideIBA
06/2003
1SaltsIBA
06/2003
1Antihypertensive Agents (Antihypertensives)IBA
06/2003
1Glucagon (Glukagon)FDA Link
06/2003
1Natriuretic AgentsIBA
06/2003